Independent clinic-based evaluation of point-of-care testing for the screening of Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis in women-at-risk in Australia, Guatemala, Morocco, and South Africa

Table 2 Estimated prevalence^a of STIs in populations surveyed, based on reference laboratory testing

Country	Chlamydia	Gonorrhoea	Trichomoniasis
Morocco	20.3% (81/399)	2.8% (11/399)	39.5% (158/400)
Guatemala (Site 1)	19.8% (17/86)	2.3% (2/86)	15.1% (13/86)
South Africa	38.2% (305/799)	20.0% (159/794)	15.6% (124/795)
Australia	Test not performed	Test not performed	17.5% (14/80)
Pooled Prevalence	31.1% (403/1284)	13.4% (172/1279)	22.7% (309/1361)

STIs = Sexually transmitted infections, Chlamydia = Chlamydia trachomatis, Gonorrhoea = Neisseria gonorrhoeae, Trichomoniasis = Trichomonas vaginalis
^aEstimate of prevalence based on positive results reported by the reference laboratory/total number of valid tests performed by the laboratory

ISSN: 1471-2334